Evidence of bias against adoption of anti-obesity pharmacotherapies
<p> Background</p><p> Approximately half of adults in the U.S. fit the criteria for use of anti-obesity pharmacotherapy, but only 2% of those receive such treatment. This is in sharp contrast to the 8.4% of adults diagnosed with diabetes, with 86% of those receiving anti-diabetes...
| Main Author: | |
|---|---|
| Language: | EN |
| Published: |
Weill Medical College of Cornell University
2016
|
| Subjects: | |
| Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=10007592 |